Massive Open Online Course on E-waste
A Joint Statement on Tourism and COVID-19 - UNWTO and WHO Call for Responsibility and Coordination
WHO announces forthcoming changes to the programmatic management of TB preventive treatment
WHO launches a digital version of its Model list of Essential Medicines (EML)
WHO steps up action to improve access to safe blood
Study reviews efficacy and safety of drugs against taeniasis caused by the pork tapeworm
France pledges US$100 million (€90 million) for WHO Academy
Global gathering of ministers determines road safety agenda to 2030
Immunization is the best protection against tick-borne encephalitis
World failing to provide children with a healthy life and a climate fit for their future: WHO-UNICEF-Lancet
WHO Action framework to advance universal access to safe, effective and quality assured blood products 2020 - 2023
Assessing national guidelines on responding to violence against children in the Eastern Mediterranean Region
WHO Global Initiative for Childhood Cancer: progress on all fronts
Executive Board supports WHO progress report on the End TB Strategy and recommends adoption of a Global Strategy for TB Research and Innovation
Four countries in the African region license vaccine in milestone for Ebola prevention
WHO Information Notice for users of malaria IVDs 2020/1
Remarks by Dr Michael Ryan, Executive Director, WHO Health Emergencies Programme at media briefing on COVID-19 on 13 February 2020
World experts and funders set priorities for COVID-19 research
International Day of Women and Girls in Science
Pregnancy and breastfeeding during an Ebola virus outbreak
A tribute to Dr LEE Jong-wook, Director-General of WHO
Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™).
Two-dose presentation of preservative-free Human Papilloma Vaccine from GlaxoSmithKline (GSK) (Cervarix™).
Statement from the Global Advisory Committee on Vaccine Safety
Suspension of Statens Serum Institute IPV supply through UN procurement
Lifting of supply suspension of Inactivated Polio Vaccine (IPV) produced by AJ Vaccines former Statens Serum Institut (SSI)
Notice of Concern (NOC) withdrawn for Cadila Healthcare Ltd
WHO statement on BCG vaccine
WHO Statement on higher than normal incidence of aggregation in Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus Influenzae Type B vaccine, ready to use (liquid) single-dose presentation, produced by Biological E. Limited, India
WHO appoints co-chairs of Independent Commission on sexual misconduct during the Ebola response in North Kivu and Ituri, the Democratic Republic of the Congo
Sixth Annual meeting of the “Friends of the Task Force” Working with Member States to deliver the NCD-related SDG targets during and beyond COVID-19
New electronic survey manual supports countries to combat micronutrient deficiencies
WHO Bulletin Call for Papers: Behavioural and Social Sciences for Better Health
WHO takes a position on genetically modified mosquitoes
RESPECT Implementation package for preventing violence against women
WHO: Global TB progress at risk
Investment in digital health needs careful planning: new WHO guide explains how to do it well
Election of WHO Director-General
WHO Executive Board shortlists candidates for Director-General
